Which medications in the drug class Anticoagulant are used in the treatment of Unstable Angina?

Updated: Oct 01, 2020
  • Author: Walter Tan, MD, MS; Chief Editor: Eric H Yang, MD  more...
  • Print


Thrombin, the end product of the coagulation mechanism, initiates transformation of fibrinogen to a fibrin clot and activates platelets. Its antagonist, antithrombin III, is the major endogenous inhibitor of the coagulation cascade and is the essential cofactor for heparin.


Heparin catalyzes the effect of antithrombin III on coagulative proteinases (eg, factors II, XII, XI, IX, and X, along with tissue factor VIIa). It prevents clot reaccumulation after endogenous fibrinolysis. When unfractionated heparin (UFH) is used, the activated partial thromboplastin time (aPTT) should not be checked until 6 hours after the initial heparin bolus.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!